BACKGROUND: Non-completion of a prescribed course of treatment occurs in 20-60% of individuals diagnosed with borderline personality disorder (BPD). While symptom severity, personality traits and environmental factors have been implicated as predictors of treatment non-completion (TNC), there have been no studies of neuropsychological predictors in this population. METHODS: From a randomized controlled trial, a subsample of 31, unmedicated outpatients diagnosed with BPD with recent self-injurious behavior was assessed on 5 neuropsychological domains. Patients were also assessed for general IQ, demographic and other salient clinical variables. Patients were randomized to one of four treatment conditions, which lasted up to 1 year. Number of weeks in treatment (WIT) up to 1 year was utilized as the index of TNC. RESULTS: Thirty-three percent of the subsample (n = 12) did not complete 1 year of treatment. However, more WIT were predicted by better baseline executive control (Trails B; p < 0.01) and visual memory performance (Benton visual retention; p < 0.001); other neuropsychological domains did not predict WIT. CONCLUSION: In the treatment of outpatients with BPD, better executive control and visual memory performance predict more WIT. Assessing and addressing these neurocognitive factors in treatment may reduce TNC in this high-risk population.
RCT Entities:
BACKGROUND: Non-completion of a prescribed course of treatment occurs in 20-60% of individuals diagnosed with borderline personality disorder (BPD). While symptom severity, personality traits and environmental factors have been implicated as predictors of treatment non-completion (TNC), there have been no studies of neuropsychological predictors in this population. METHODS: From a randomized controlled trial, a subsample of 31, unmedicated outpatients diagnosed with BPD with recent self-injurious behavior was assessed on 5 neuropsychological domains. Patients were also assessed for general IQ, demographic and other salient clinical variables. Patients were randomized to one of four treatment conditions, which lasted up to 1 year. Number of weeks in treatment (WIT) up to 1 year was utilized as the index of TNC. RESULTS: Thirty-three percent of the subsample (n = 12) did not complete 1 year of treatment. However, more WIT were predicted by better baseline executive control (Trails B; p < 0.01) and visual memory performance (Benton visual retention; p < 0.001); other neuropsychological domains did not predict WIT. CONCLUSION: In the treatment of outpatients with BPD, better executive control and visual memory performance predict more WIT. Assessing and addressing these neurocognitive factors in treatment may reduce TNC in this high-risk population.
Authors: Efrat Aharonovich; Deborah S Hasin; Adam C Brooks; Xinhua Liu; Adam Bisaga; Edward V Nunes Journal: Drug Alcohol Depend Date: 2005-09-19 Impact factor: 4.492
Authors: Eric A Fertuck; Sofia Marsano-Jozefowicz; Barbara Stanley; Warren W Tryon; Maria Oquendo; J John Mann; John G Keilp Journal: J Pers Disord Date: 2006-02
Authors: Michael I Posner; Mary K Rothbart; Nathalie Vizueta; Kenneth N Levy; David E Evans; Kathleen M Thomas; John F Clarkin Journal: Proc Natl Acad Sci U S A Date: 2002-11-27 Impact factor: 11.205
Authors: John M Oldham; Donna S Bender; Andrew E Skodol; Ingrid R Dyck; Charles A Sanislow; Shirley Yen; Carlos M Grilo; M Tracie Shea; Mary C Zanarini; Edd John G Gunderson; Thomas H McGlashan Journal: J Psychiatr Pract Date: 2004-05 Impact factor: 1.325
Authors: Haruhiko Banno; Kelly L Andrzejewski; Michael P McDermott; Alyssa Murphy; Madhurima Majumder; Elisabeth A de Blieck; Peggy Auinger; Merit E Cudkowicz; Nazem Atassi Journal: J Huntingtons Dis Date: 2017
Authors: Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen Journal: Cochrane Database Syst Rev Date: 2020-05-04